Lower GI 2017
RAPIDO Trial
N = 885 patients
SCPRT 5X5 GY
CapOx + 6
R A N D
T M
Capecitabine: Oxaliplatin:
825 mg/m2 130 mg/m2
T4
EMVI+ N2 CRM+
O M I Z A T I
E
Standard CRT 50.4Gy
O N
Primary endpoint 3 year DFS
Made with FlippingBook
RAPIDO Trial
N = 885 patients
SCPRT 5X5 GY
CapOx + 6
R A N D
T M
Capecitabine: Oxaliplatin:
825 mg/m2 130 mg/m2
T4
EMVI+ N2 CRM+
O M I Z A T I
E
Standard CRT 50.4Gy
O N
Primary endpoint 3 year DFS
Made with FlippingBook